Oral administration of exopolysaccharide from Aphanothece halophytica (Chroococcales) significantly inhibits influenza virus (H1N1)-induced pneumonia in mice

International Immunopharmacology

Volumn 6, Issue 7, 2006, Pages 1093-1099

  Zheng, Weifa ^a   Chen, Caifa ^a   Cheng, Qiping ^b   Wang, Yiqin ^c   Chu, Chengcai ^c  

^a JIANGSU NORMAL UNIVERSITY   (China)

^b ANHUI NORMAL UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Chroccoccales; Exopolysaccharide from Aphanothece halophytica Fremy; FM1 induced pneumonia; Immunomodulation

Indexed keywords

BACTERIAL POLYSACCHARIDE; EXOPOLYSACCHARIDE; INTERLEUKIN 1BETA; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYANOBACTERIUM; DOSE RESPONSE; DRUG INHIBITION; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMMUNOMODULATION; INFLUENZA VIRUS A; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS INFECTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; CYANOBACTERIA; ENDOTOXINS; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERLEUKIN-1; KILLER CELLS, NATURAL; LYMPHOCYTES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED ICR; ORTHOMYXOVIRIDAE INFECTIONS; PHAGOCYTOSIS; PNEUMONIA, VIRAL; POLYSACCHARIDES, BACTERIAL; RETICULOENDOTHELIAL SYSTEM; SPLEEN;

EID: 33646555068     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.01.020     Document Type: Article

References (29)

1. Drews G., and Weckesser J. Function, structure and composition of cell walls and external layers. In: Carr N.G., and Whitton B.A. (Eds). The biology of cyanobacteria (1982), Blackwell, Oxford 333-357
2. Li P.F., Liu Z.L., and Xu R. Chemical characterization of the released polysaccharide from the cyanobacterium Aphanothece halophytica GR02. J Appl Phycol 13 (2001) 71-77
3. Yu S.C., and Zhang Y.Z. Effects of Achyranthes bioentata polysaccharides on antitumor activity and immune function of S-180 bearing mice. Chin J Oncol 17 (1995) 275-278
4. Zhou L., and Meng Y.M. Studies on antiviral activity of polysaccharides and their derivatives. Chin J Appl Environ Biol 3 (1997) 82-90
5. Li H., Wei P., and Ouyang P.K. Isolation, purification and physicochemical properties of the exopolysaccharides from Aphanothece halophytica. Nat Prod Res Dev 12 (2000) 52-56
6. Nergard C.S., Diallo D., Michaelsen T.E., Malterud K.E., Kiyohara H., Matsumoto T., et al. Isolation, partial characterisation and immunomodulating activities of polysaccharides from Vernonia kotschyana Sch. Bip. ex Walp. J Ethonopharmacol 91 (2004) 141-152
7. Zheng W.F., Chen C.F., and Cheng Q.P. Antitumor activity of exopolysaccharide from Aphanothece halophytica. Chin Tradit Herbal Drugs 36 (2005) 1026-1030
8. Ba DN. Contemporary Immunological Technology and application. United Press of Beijing Medical University and China Union Medical University: Beijing; 1998. p. 49-71.
9. Biron C.A. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 9 (1997) 24-34
10. Hoshino S., Sun Z., and Uchikura K. Biliary obstruction reduces hepatic killing and phagocytic clearance of circulating microorganisms in rats. J Gastrointest Surg 7 (2003) 497-506
11. Yopp J.H., Tindall D.R., Miller D.M., and Schmid W.E. Isolation, purification and evidence for a halophilic nature of the blue-green alga Aphanthece halophytica Frémy (Chroococcales). Phycologia 17 (1978) 172-178
12. Borowitzka M.A. Algal growth media and sources of algal cultures. In: Borowitzka M.A., and Borowitzka L.J. (Eds). Micro-algal biotechnology (1988), Cambridge U.P, Cambridge 456-465
13. Ovalle R., Soll C.E., Lim F., Flanagan C., Rotunda T., and Lipke P.N. Systematic analysis of oxidative degradation of polysaccharides using PAGE and HPLC-MS. Carbohydr Res 330 (2001) 131-139
14. Bolke E., Jehle P.M., Storck M., Nothnagel B., Stanescu A., and Orth K. Endotoxin release and endotoxin neturalizing capacity during clonoscopy. Clin Chim Acta 303 (2000) 49-53
15. Boyd M.R., and Beeson M.F. Animal models for evaluation of compounds against influenza viruses. J Antimicrob Chemother 1 (1975) 43-47
16. Fasanmade A.A., and Jusko W.J. Optimizing whole blood lymphocyte proliferation in the rat. J Immunol Methods 184 (1995) 163-167
17. + T cell proliferation in bovine leukemia virus infected animals with persistent lymphocytosis. J Immunol Methods 199 (1996) 159-165
18. Moretao M.P., Buchi D.F., Gorin P.A.J., Iacomini M., and Oliveira M.B.M. Effect of an acidic heteropolysaccharide (ARAGAL) from the gum of Anadenanthera colubrina (Angico branco) on peritoneal macrophage functions. Immunol Lett 89 (2003) 175-185
19. Valadares M.C., Klein S.I., Guaraldo A.M.A., and Queiroz M.L.S. Enhancement of natural killer cell function by titanocenes in mice bearing Ehrlich ascites tumour. Eur J Pharmacol 473 (2003) 191-196
20. Nakamura H., Tamura S.I., Watanabe Z., Iwasaki T., and Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett 82 (2002) 165-170
21. Hoopera P., Zakib S., Danielsa P., and Middletona D. Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect 3 (2001) 315-322
22. Andrei G., Snoeck R., Schols D., Goabau P., Desmyter J., and De Clercq E. Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalo virus. Eur J Microbiol (Infect. Dis.) 10 (1991) 1026-1033
23. Ehresmann D., Deig E.F., and Hatch M.T. Antiviral properties of algal polysaccharides and related compounds. In: Hoppe H., Levring T., and Tanaka Y. (Eds). Marine algae in pharmaceutical science (1979), Walter de Gruyter, Berlin, New York 293-302
24. Witvrouw M., and De Clercq E. Sulfated polysaccharide extracted from sea algae as potential antiviral drugs. Gen Pharmacol 29 (1997) 497-511
25. Hatch M., Ehresmann D., Deig E., and Wedros N. Further studies on the chemical composition and an initial in vivo evaluation of antiviral material in extracts of macroscopic algae. J Phycol (S) 13 (1977) 28-35
26. Dimitrov S., Lange T., Tieken S., Fehm H.L., and Born J. Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans. Brain Behav Immun 18 (2004) 341-348
27. + T cells. Immunol Rev 123 (1991) 209-215
28. Chakraborti T., Mandal A., Mandal M., Das S., and Chakraborti S. Complement activation in heart diseases: role of oxidants. Cell Signal 12 (2000) 607-617
29. Vishwas D.J., Dhananjaya V.K., and Alan S.C. Simultaneous activation of apoptosis and inflammation in pathogenesis of septic shock: a hypothesis. FEBS Lett 555 (2003) 180-184